(Q35409780)

8 August 2017

1 reference

title

PROBLEMS IN THE MANAGEMENT OF LONG-TERM ANTICOAGULANT THERAPY IN CORONARY HEART DISEASE. (English)

1 reference

8 August 2017

1 reference

MANCHESTER B

1

1 reference

8 August 2017

publication date

1 November 1963

1 reference

Progress in Cardiovascular Diseases

8 August 2017

published in

1 reference

8 August 2017

volume

6

1 reference

8 August 2017

page(s)

272-298

1 reference

Anticoagulants in acute myocardial infarction

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Long-term anticoagulant therapy after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Survival after recent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The fate of patients surviving acute myocardial infarction; a study of clinical and necropsy data in two hundred fifty cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The long-term prognosis following myocardial infarction, and some factors which affect it

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The spectrum of coronary heart disease in a community of 30,000. A clinicopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Prognosis and anticoagulant pro-phylaxis after coronary occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Atherosclerosis and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Indications for anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The effect of permanent anticoagulant therapy on symptoms and mortality in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Anticoagulant treatment of obliterative pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Pulmonary embolism. A study of late prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The effect of dicumarol upon the mortality and incidence of thromboembolic complications in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Dicumarol therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Dicumarol prophylaxis of thromboembolic disease in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Evaluation of anticoagulant therapy in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The thromboplastin generation test

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Action of Coumarin Anticoagulants on a Possible New Serum Clotting Factor

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The function factor VII

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Myocardial infarction in a haemophiliac

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Co-thromboplastin, a probable factor in coagulation of blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Thrombotest. A new method for controlling anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

A new test for anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Blood thrombotest versus prothrombin test. Comparison in patients maintained on bishydroxycoumarin and related drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Owren's capillary blood thrombotest for office or bedside control of anticoagulant therapy: an evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Control of anticoagulant therapy with the thrombotest. Comparison with the Quick test

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Thrombotest versus one-stage prothrombin-time determination

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Laboratory control of coumarin therapy: the clinician's dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Control of anticoagulant therapy. The use of new tests

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Anticoagulant therapy with coumarin congeners. Action and guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Prothrombin; a critique of methods for its determination and their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Thrombelastographic study of 76 patients on long-term anticoagulant therapy with coumarin-type drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The prevention of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The value of continuous (1 to 10 years) long-term anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

An appraisal of the newer electrocardiography: correlations in one hundred and fifty consecutive autopsied cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Myocardial Infarction and Atrial Arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Cardiac infarction with bundle branch block

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Measurements of enzymes in the diagnosis of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Evaluation of enzyme tests in the diagnosis of heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Serum LDH activity in pulmonary embolism diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

An evaluation of the effect of continuous long-term anticoagulant therapy on the prognosis of myocardial infarction: a report of 82 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Long-term treatment with dicumarol in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Survival rates after acute myocardial infarction with long-term anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Long-term anticoagulant therapy in coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Long-term anticoagulant therapy in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Long-term anticoagulant therapy after acute myocardial infarction. A retrospective study based upon a nine-year experience at the University of Chicago

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Effect of Dicumarol on Blood Vascular Integrity in the Rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The plasma protein-thyroid hormone complex in man. III. Further studies on the use of the in vitro red blood cell up take of I 131-1-triiodothyronine as a diagnostic test of thyroid function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The uricosuric action of ethyl biscoumacetate

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

The prevention of the generalized Shwartzman reaction with sodium warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Thrombosis in the presence of vascular stasis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

Increased Clotting Factors in Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2863%2980039-0

7 January 2021

10.1016/S0033-0620(63)80039-0

Identifiers

DOI

1 reference

8 August 2017

1 reference